(Q48713890)

14 February 2018

title

Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition (English)

1 reference

14 February 2018

0 references

Das P

1

1 reference

14 February 2018

Murphy MP

2

1 reference

14 February 2018

Younkin LH

3

1 reference

14 February 2018

Younkin SG

4

1 reference

14 February 2018

Golde TE

5

1 reference

14 February 2018

publication date

1 September 2001

1 reference

14 February 2018

published in

Neurobiology of Aging

1 reference

14 February 2018

volume

22

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

page(s)

721-727

1 reference

14 February 2018

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

A tale of two T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

Amyloid fibril toxicity in Alzheimer's disease and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900245-7

7 January 2021

10.1016/S0197-4580(01)00245-7

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018